Drug for treatment of breast cancer with antler and ginseng as sovereign drug and preparation method and application thereof
US-2025281559-A1 · Sep 11, 2025 · US
Composition comprising scirpusin A and scirpusin B and anti-obesity potential thereof
US10172903B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10172903-B2 |
| Application number | US-201615213655-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 19, 2016 |
| Priority date | Jul 18, 2012 |
| Publication date | Jan 8, 2019 |
| Grant date | Jan 8, 2019 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed are methods of managing hypercholesterolemia using a composition of matter comprising the ethyl acetate fraction of the extract of Cyperus rotundus rhizomes standardized to contain 5% of total stilbenes.
First claim
Opening claim text (preview).
We claim: 1. A method of treating hypercholesterolemia in a human, said method comprising step of administering to said human orally twice a day, a composition derived from bioactivity guided fractionation of ethyl acetate extract of the rhizomes of Cyperus rotundus , wherein: said composition is standardized to contain 5% w/w of total stilbenes to achieve the effects of (a) reduction in the systemic levels of total cholesterol, LDL, VLDL and serum triglycerides and (b) enhancement in the systemic levels of HDL, and the composition consists essentially of a combination of piceatannol, scirpusin B, and scirpusin A. 2. A method of treating hypercholesterolemia in humans, said method comprising step of administering to said humans orally twice a day, composition derived from bioactivity guided fractionation of ethyl acetate extract of the rhizomes of Cyperus rotundus , wherein: said composition is standardized to contain greater than 3% w/w of total stilbenes to achieve the effects of (a) reduction in the systemic levels of total cholesterol, LDL, VLDL and serum triglycerides and (b) enhancement in the systemic levels of HDL, and the composition consists essentially of a combination of piceatannol, scirpusin B, and scirpusin A.
Assignees
Inventors
Classifications
- A61K36/8905Primary
Cyperus (flatsedge) · CPC title
condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone · CPC title
carbocyclic · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10172903B2 cover?
- Disclosed are methods of managing hypercholesterolemia using a composition of matter comprising the ethyl acetate fraction of the extract of Cyperus rotundus rhizomes standardized to contain 5% of total stilbenes.
- Who is the assignee on this patent?
- Majeed Muhammed, Nagabhushanam Kalyanam, Kalman Douglas, and 6 more
- What technology area does this patent fall under?
- Primary CPC classification A61K36/8905. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).